World Dec 22, 2020
Preparations for the vaccine roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain caused chaos across the region.
Preparations for the vaccine roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain caused chaos across the region.
World looks to spring for pandemic relief as vaccinations start
The developed world could start to emerge from the deadly grip of the pandemic by late spring if the first wave of COVID-19 vaccines are deployed effectively.
Pfizer first drugmaker to seek COVID-19 vaccine approval in Japan
Officials said the approval would be made "a top priority in the screening process" once the firm submits data from an ongoing clinical trial specific to Japan, expected in February.
The Pharmaceuticals and Medical Devices Agency raised questions about the way tests were performed and the criteria for determining whether symptoms had improved, sources say.
WHO plan risks leaving poor nations with no COVID-19 vaccines until 2024
Documents show the program's promoters say it is struggling from a lack of funds, supply risks and complex contractual arrangements which could make it impossible to achieve its goals.
With goal of herd immunity, Indonesia will give younger people vaccines first
The country is targeting the people who are most mobile due to their jobs, as well as regions with the highest number of coronavirus cases.
A weapon to ‘win the war’: U.S. hospitals get initial coronavirus shots
The arrival of the Pfizer-BioNTech vaccine offers a glimmer of hope amid a pandemic that has already seen almost 300,000 Americans die.
Singapore has become the first Asian country to approve the Pfizer-BioNTech coronavirus vaccine and said it expects to start receiving shots by the end of the year. Prime Minister Lee Hsien Loong, 68, said Monday he would be among the early recipients in the city-state ...
Why Japan is largely a spectator in the coronavirus vaccine race
A total of 52 vaccine candidates were in clinical evaluation worldwide as of Tuesday, of which only one was Japanese.
U.S. nears final COVID-19 vaccine review as daily deaths top 3,250
Steady movement toward a vaccine rollout on the eve of a critical review by leading U.S. medical experts comes as COVID-19 caseloads surged alarmingly higher, straining health care systems.
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
China’s state-backed coronavirus vaccine has 86% efficacy, says UAE
China’s state-backed coronavirus vaccine protected 86% of people from getting COVID-19 in trials conducted in the United Arab Emirates, reported media outlets including Reuters, citing the UAE’s health ministry. The vaccine, developed by Sinopharm unit China National Biotec Group Co., has been granted emergency use ...